Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
ISSNs: , 1464-3405
References in Bioorganic & medicinal chemistry letters:
| Title | Authors | Year |
|---|---|---|
| 7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity. | Xu WC, Wright GE, Brown NC, Long ZY, Zhi CX, Dvoskin S, Gambino JJ, Barnes MH, Butler MM | 2011 |
| N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. | Mitchell ML, Son JC, Guo H, Im YA, Cho EJ, Wang J, Hayes J, Wang M, Paul A, Lansdon EB, Chen JM, Graupe D, Rhodes G, He GX, Geleziunas R, Xu L, Kim CU | 2010 |
| Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC. | Rose Y, Ciblat S, Reddy R, Belley AC, Dietrich E, Lehoux D, McKay GA, Poirier H, Far AR, Delorme D | 2006 |
| Photoregulation of DNA polymerase I (Klenow) with caged fluorescent oligodeoxynucleotides. | Tang X, Richards JL, Peritz AE, Dmochowski IJ | 2005 |
| Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues. | Ludovici DW, Kavash RW, Kukla MJ, Ho CY, Ye H, De Corte BL, Andries K, De Béthune MP, Azijn H, Pauwels R, Moereels HE, Heeres J, Koymans LM, De Jonge MR, Van Aken KJ, Daeyaert FF, Lewi PJ, Das K, Arnold E, Janssen PA | 2001 |
| Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU). | Ludovici DW, Kukla MJ, Grous PG, Krishnan S, Andries K, De Béthune MP, Azijn H, Pauwels R, De Clercq E, Arnold E, Janssen PA | 2001 |
| Enzymatic synthesis of labeled DNA by PCR using new fluorescent thymidine nucleotide analogue and superthermophilic KOD dash DNA polymerase. | Obayashi T, Masud MM, Ozaki AN, Ozaki H, Kuwahara M, Sawai H | 2002 |
| Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates. | Dash C, Ahmadibeni Y, Hanley MJ, Pandhare J, Gotte M, Le Grice SF, Parang K | 2011 |
| Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). | Zhao Z, Wolkenberg SE, Sanderson PE, Lu M, Munshi V, Moyer G, Feng M, Carella AV, Ecto LT, Gabryelski LJ, Lai MT, Prasad SG, Yan Y, McGaughey GB, Miller MD, Lindsley CW, Hartman GD, Vacca JP, Williams TM | 2008 |
| Nucleosides and nucleotides. 183. Synthesis of 4'alpha-branched thymidines as a new type of antiviral agent. | Sugimoto I, Shuto S, Mori S, Shigeta S, Matsuda A | 1999 |
| Effects of 8-chlorodeoxyadenosine on DNA synthesis by the Klenow fragment of DNA polymerase I. | Chen LS, Bahr MH, Sheppard TL | 2003 |
| Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis. | Kirschberg TA, Balakrishnan M, Huang W, Hluhanich R, Kutty N, Liclican AC, McColl DJ, Squires NH, Lansdon EB | 2008 |
| Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. | Pungitore CR, León LG, García C, Martín VS, Tonn CE, Padrón JM | 2007 |
| 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase. | Larsen SD, Zhang Z, DiPaolo BA, Manninen PR, Rohrer DC, Hageman MJ, Hopkins TA, Knechtel ML, Oien NL, Rush BD, Schwende FJ, Stefanski KJ, Wieber JL, Wilkinson KF, Zamora KM, Wathen MW, Brideau RJ | 2007 |
| Synthetic analogues of the manzamenones and plakoridines which inhibit DNA polymerase. | Doncaster JR, Etchells LL, Kershaw NM, Nakamura R, Ryan H, Takeuchi R, Sakaguchi K, Sardarian A, Whitehead RC | 2006 |
| Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants. | Su DS, Lim JJ, Tinney E, Wan BL, Young MB, Anderson KD, Rudd D, Munshi V, Bahnck C, Felock PJ, Lu M, Lai MT, Touch S, Moyer G, Distefano DJ, Flynn JA, Liang Y, Sanchez R, Prasad S, Yan Y, Perlow-Poehnelt RA, Torrent M, Miller MD, Vacca JP, Williams TM, Anthony NJ | 2009 |
| Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-benzyl derivatives with broad potency against resistant mutant viruses. | Kertesz DJ, Brotherton-Pleiss C, Yang M, Wang Z, Lin X, Qiu Z, Hirschfeld DR, Gleason SK, Mirzadegan T, Dunten PW, Harris SF, Villaseñor AG, Hang JQ, Heilek GM, Klumpp K | 2010 |
| Incorporation of 4-thiothymidine into DNA by the Klenow fragment and HIV-1 reverse transcriptase. | Rao TV, Haber MT, Sayer JM, Jerina DM | 2000 |
| Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase. | Sweeney ZK, Dunn JP, Li Y, Heilek GM, Dunten PW, Elworthy TR, Han X, Harris SF, Hirschfeld DR, Hogg JH, Huber W, Kaiser AC, Kertesz DJ, Kim W, Mirzadegan T, Roepel MG, Saito YD, Silva TM, Swallow S, Tracy JL, Villasenor A, Vora H, Zhou AS, Klumpp K | 2008 |
| Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. | Ludovici DW, De Corte BL, Kukla MJ, Ye H, Ho CY, Lichtenstein MA, Kavash RW, Andries K, De Béthune MP, Azijn H, Pauwels R, Lewi PJ, Heeres J, Koymans LM, De Jonge MR, Van Aken KJ, Daeyaert FF, Das K, Arnold E, Janssen PA | 2001 |
| The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations. | Tucker TJ, Saggar S, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai MT, Liang Y, McGaughey GB, Liu M, Miller MD, Moyer G, Munshi V, Perlow-Poehnelt RA, Prasad S, Sanchez R, Torrent M, Vacca JP, Wan BL, Yan Y | 2008 |
| Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase. | Vaillancourt VA, Cudahy MM, Staley SA, Brideau RJ, Conrad SJ, Knechtel ML, Oien NL, Wieber JL, Yagi Y, Wathen MW | 2000 |
| Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III. | Guiles JW, Sun X, Critchley IA, Ochsner U, Tregay M, Stone K, Bertino J, Green LS, Sabin R, Dean F, Dallmann HG, McHenry CS, Janjic N | 2009 |
| N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. | Mitchell ML, Son JC, Lee IY, Lee CK, Kim HS, Guo H, Wang J, Hayes J, Wang M, Paul A, Lansdon EB, Chen JM, Eisenberg G, Geleziunas R, Xu L, Kim CU | 2010 |
| Small molecule inhibitors of HIV RT Ribonuclease H. | Di Grandi M, Olson M, Prashad AS, Bebernitz G, Luckay A, Mullen S, Hu Y, Krishnamurthy G, Pitts K, O'Connell J | 2010 |
| Construction of saccharide-modified DNAs by DNA polymerase. | Matsui M, Nishiyama Y, Ueji S, Ebara Y | 2007 |
| Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III. | Ali A, Aster SD, Graham DW, Patel GF, Taylor GE, Tolman RL, Painter RE, Silver LL, Young K, Ellsworth K, Geissler W, Harris GS | 2001 |
| Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains. | Barreca ML, Rao A, De Luca L, Iraci N, Monforte AM, Maga G, De Clercq E, Pannecouque C, Balzarini J, Chimirri A | 2007 |
| 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase. | Tang J, Maddali K, Dreis CD, Sham YY, Vince R, Pommier Y, Wang Z | 2011 |
| Enantioselective binding of second generation pyrrolobenzoxazepinones to the catalytic ternary complex of HIV-1 RT wild-type and L100I and K103N drug resistant mutants. | Butini S, Gemma S, Brindisi M, Borrelli G, Fiorini I, Samuele A, Karytinos A, Facchini M, Lossani A, Zanoli S, Campiani G, Novellino E, Focher F, Maga G | 2011 |
| Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase. | Wang Z, Vince R | 2008 |
| Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses. | Tang G, Kertesz DJ, Yang M, Lin X, Wang Z, Li W, Qiu Z, Chen J, Mei J, Chen L, Mirzadegan T, Harris SF, Villaseñor AG, Fretland J, Fitch WL, Hang JQ, Heilek GM, Klumpp K | 2010 |
| 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series. | He Y, Chen F, Sun G, Wang Y, De Clercq E, Balzarini J, Pannecouque C | 2004 |
| Inhibition of tubulin polymerization by select alkenyldiarylmethanes. | Cullen MD, Sarkar T, Hamel E, Hartman TL, Watson KM, Buckheit RW, Pannecouque C, De Clercq E, Cushman M | 2008 |
| Identification of a novel family of nucleosides that specifically inhibit HIV-1 reverse transcriptase. | Chamorro C, Lobatón E, Bonache MC, De Clercq E, Balzarini J, Velázquez S, San-Félix A, Camarasa MJ | 2001 |
| Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs. | Zhan P, Li X, Li Z, Chen X, Tian Y, Chen W, Liu X, Pannecouque C, De Clercq E | 2012 |
| 4'C-ethynyl-thymidine acts as a chain terminator during DNA-synthesis catalyzed by HIV-1 reverse transcriptase. | Summerer D, Marx A | 2005 |
| 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors. | Zhan P, Liu X, Cao Y, Wang Y, Pannecouque C, De Clercq E | 2008 |
| Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors. | Cullen MD, Cheung YF, Houslay MD, Hartman TL, Watson KM, Buckheit RW, Pannecouque C, De Clercq E, Cushman M | 2008 |
| Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility. | Bollini M, Frey KM, Cisneros JA, Spasov KA, Das K, Bauman JD, Arnold E, Anderson KS, Jorgensen WL | 2013 |
| Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. | Chen X, Liu X, Meng Q, Wang D, Liu H, De Clercq E, Pannecouque C, Balzarini J, Liu X | 2013 |